36 results
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... hypovolemia) • GU infections ... (e.g. ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... mL/minute/1.73 m2 ... side effects (e.g ... #Metformin #Pharmacology ... #Summary #DM2 #
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
Bydureon (Exenatide ER ... are subcutaneous injections ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... Dosing #Diabetes #DM2
Hydroxychloroquine in COVID-19 - How might hydroxychloroquine help combat a COVID-19 infection?

It's important to remember that
combat a COVID-19 infection ... ATL MedStudent COVID ... #Coronavirus #Pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... opportunistic #infections ... #HIVAIDS #pharmacology
Impact and Challenges With Vitamin D to Treat Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
Ergocalciferol (D2 ... kidney function ER ... Nephrology #Management #Pharmacology
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... prior resistance. e.g ... #antibiogram #pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
0.3-0.6 units/kg ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Treating Acute Infection ... amphotericin B, 3 to 5 mg/kg ... opportunistic #infections ... #HIVAIDS #pharmacology